Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 5-HT1 receptor family comprises a group of five G protein-coupled receptors (GPCRs): 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, and 5-HT1F. These receptors are primarily coupled to Gi/Go proteins, inhibiting adenylyl cyclase and reducing cAMP formation. They are widely distributed throughout the central nervous system and play crucial roles in regulating mood, anxiety, aggression, and neurotransmitter release. Specific subtypes like 5-HT1A and 5-HT1B function as autoreceptors, controlling serotonin neuron firing and serotonin release, respectively. Drugs targeting these receptors, such as buspirone (5-HT1A partial agonist) and triptans (5-HT1B/1D/1F agonists), are used in the treatment of anxiety, depression, and migraine.
Agonism or antagonism at 5-HT1 receptor subtypes, leading to modulation of adenylyl cyclase activity and downstream signaling pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor 5-HT1 Family (5-HT1 Family).